Category Archives: Big Pharma WatchDecades ago, clinical trials were conducted at academic settings that focused on the acquisition of knowledge and the completely objective discoveries of drugs and devices to benefit mankind. Then, in 1980, the Bayh-Dole Act, Public Law 96-517,was created, which allowed for such places with their researchers to profit off of their discoveries that were performed for pharmaceutical companies and others in the past.
Pharmaceutical companies manipulate the trials they sponsor because of their power to control others involved in the process largely absent of regulation. This is a matter of requiring authenticity and, more importantly, assuring the safety of the public health.
Pfizer has announced its reorganization strategy with Wyeth. The research operations will be broken into two units: a biotechnology unit led by a Wyeth senior executive, and a pharmaceutical group led by a Pfizer scientist. The plan hopes to smoothly integrate Pfizer and Wyeth after the acquisition closes later this year. The Wyeth acquisition has [...]
Although women are certainly not the only targets of Big Pharma drug ads, winning the female audience is critical to the success of any given drug. Women are more proactive about their health, more likely to “talk to their doctor”, more likely to encourage their husbands to seek medical treatment, and more likely to manage the healthcare for the entire family.
Published at www.nejm.org March 18, 2009 (10.1056/NEJMe0902377) The Medical Device Safety Act of 2009 Gregory D. Curfman, M.D., Stephen Morrissey, Ph.D., and Jeffrey M. Drazen, M.D. PDF Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation Challenges for the FDA: the future of drug safety — workshop summary. [...]
The information in this post was gathered from an article published by Deb Bortifz in eCliniqua, Innovative Management in Clinical Trials. eCliniqua offers PodCasts, WebCasts, White Papers and much more. Their ‘data-rich’ site is one of my primary research resources for an objective review of clinical trial process and results. March 16, 2009 | Pfizer [...]
Will Open Source “SAGE” platform lead to more transperency to MERCK’s research and clinical trials process? Consumers can only hope. Of course if MERCK corporate lawyers figure out that such an open source platform may lead to a clear chain of custody of the type of information they would rather not have readily available during [...]
If you are currently taking prescription prenatal and iron supplements, check with your health your health provider. FOR IMMEDIATE RELEASE — St. Louis, MO, February 3, 2009 – ETHEX Corporation, a subsidiary of KV Pharmaceutical Company (NYSE: KVa/KVb), is issuing a voluntary nationwide recall of the products identified below (all lots within their expiration dates) [...]
Goal Is to Provide Signs of Possibility Of Adverse Effect By JARED A. FAVOLE Wall Street Journal WASHINGTON The Food and Drug Administration on Friday unveiled a report listing 20 drugs that the agency is investigating for potential side effects, as part of a new policy to warn patients and health-care professionals as early [...]
A BIG thank you to the Philadelphia Inquirer… One of the few major media outlets that consistently cover Big Pharma and the FDA… This weekend The Philadelphia Inquirer examined how Sen. Chuck Grassley (R-Iowa) has “found a congressional calling” in “creating uproars that often transform public opinion and policy” and “in recent years … has [...]
© 2002- An Inconvenient Woman. Site design and construction by Pleiades Publishing Services, Co.
Powered by Wordpress and based on the template design MyJournal Hypereal by 
BlogoSquare
